Try our beta test site
IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more...
4 studies found for:    "Factor VII deficiency"
Show Display Options
Rank Status Study
1 Completed Treatment of Inherited Factor VII Deficiency
Condition: Factor VII Deficiency
Interventions: Drug: plasma derived Factor VII;   Drug: recombinant FVIIa;   Drug: Fresh Frozen Plasma;   Drug: Activated Prothrombin Complex Concentrates;   Drug: Virus Inactivated plasma
2 Recruiting Study Comparing the Pharmacokinetic of Biosimilar Eptacog Alfa With Novoseven®, in Patients With Congenital Factor VII Deficiency
Condition: Factor VII Deficiency
Interventions: Biological: Eptacog alfa, biosimilar and reference medicinal product Novoseven;   Biological: Eptacog alfa biosimilar
3 Completed Study of the Pharmacokinetics and Safety of Recombinant Factor VIIa Fusion Protein (rVIIa-FP, CSL689) in Patients With Congenital Factor VII Deficiency
Condition: Congenital Coagulation Factor VII Deficiency
Interventions: Biological: Eptacog alfa (activated) or pdFVII;   Biological: CSL689
4 Completed Treatment of Congenital Factor VII Deficiency
Conditions: Congenital Bleeding Disorder;   Congenital FVII Deficiency
Interventions: Drug: activated recombinant human factor VII;   Drug: Fresh frozen plasma (Source unspecified);   Drug: Plasma-derived FVII (LFB);   Drug: Prothrombin Complex conc. (PCC);   Drug: Plasma-derived FVII conc. (pdFVII Baxter);   Drug: Plasma-derived FVII conc. (pdFVII PFL)

Study has passed its completion date and status has not been verified in more than two years.